Gamal Esmat
About
In The Last Decade
Gamal Esmat
274 papers receiving 5.4k citations
Peers
Comparison fields: 5 of 143
- Hepatology 3.4k
- Epidemiology 3.3k
- Molecular Biology 696
- Parasitology 577
- Cancer Research 516
Countries citing papers authored by Gamal Esmat
This map shows the geographic impact of Gamal Esmat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gamal Esmat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gamal Esmat more than expected).
Fields of papers citing papers by Gamal Esmat
This network shows the impact of papers produced by Gamal Esmat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gamal Esmat. The network helps show where Gamal Esmat may publish in the future.
Co-authorship network of co-authors of Gamal Esmat
This figure shows the co-authorship network connecting the top 25 collaborators of Gamal Esmat. A scholar is included among the top collaborators of Gamal Esmat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gamal Esmat. Gamal Esmat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 9 | |
| 4 | 6 | |
| 5 | 3 | |
| 6 | COVID-19 vaccine acceptance and its associated factors among people living with HIV (PLHIV) in the Middle East and North Africa (MENA) region: a cross-sectional multi-centre study | 1 |
| 7 | 18 | |
| 8 | 23 | |
| 9 | 2 | |
| 10 | 30 | |
| 11 | 5 | |
| 12 | Noninvasive Assessment of Liver Fibrosis in Egyptian Children with Chronic Liver Diseases. | 9 |
| 13 | 7 | |
| 14 | 1 | |
| 15 | 2 | |
| 16 | Transient Elastography can Predict the Risk of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C | 0 |
| 17 | Impact of Serum Alpha-fetoprotein Levels on the Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C | 3 |
| 18 | 0 | |
| 19 | 16 | |
| 20 | Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C. | 40 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.